Send us a text

For our Season 9 opening episode, we're learning about agnostic 
treatments in cancer with Dr. Richard Schilsky of ASCO, who discusses the 
TAPUR Study. You may wonder, what is TAPUR and how does it relate to agnostic
treatments?  The pioneer behind the study, Dr. Schilsky, explains clinical trials for agnostic therapeutics, how you can join a TAPUR trial, and what to expect.